Subsequent approval of the ALTO Abdominal Stent Graft System and commercialization occurred in 2020. “The publication of results of the ELEVATE Study represent a foundational block of the evidence ...
IRVINE, Calif.--(BUSINESS WIRE)--Endologix LLC, a leader in the treatment of vascular disease, today announced the first implant of its ALTO® Abdominal Stent Graft in Canada following recent approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback